43,662 Shares in SWK Holdings Co. (NASDAQ:SWKH) Purchased by Rangeley Capital LLC

Rangeley Capital LLC bought a new stake in SWK Holdings Co. (NASDAQ:SWKH) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 43,662 shares of the company’s stock, valued at approximately $692,000. Rangeley Capital LLC owned approximately 0.36% of SWK at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. JPMorgan Chase & Co. boosted its position in SWK by 102.2% during the fourth quarter. JPMorgan Chase & Co. now owns 12,350 shares of the company’s stock worth $196,000 after acquiring an additional 6,242 shares during the last quarter. Barclays PLC grew its position in SWK by 185.0% during the third quarter. Barclays PLC now owns 4,461 shares of the company’s stock valued at $77,000 after acquiring an additional 2,896 shares during the period. Grace & White Inc. NY increased its position in SWK by 11.1% during the 4th quarter. Grace & White Inc. NY now owns 18,721 shares of the company’s stock worth $297,000 after purchasing an additional 1,871 shares in the last quarter. Finally, SkyView Investment Advisors LLC raised its stake in shares of SWK by 2.1% in the 3rd quarter. SkyView Investment Advisors LLC now owns 31,815 shares of the company’s stock valued at $550,000 after acquiring an additional 650 shares during the period. 99.27% of the stock is currently owned by institutional investors and hedge funds.

SWK Stock Performance

SWK stock opened at $17.54 on Thursday. The company has a debt-to-equity ratio of 0.11, a current ratio of 5.06 and a quick ratio of 5.06. SWK Holdings Co. has a 12-month low of $15.14 and a 12-month high of $18.09. The firm’s fifty day moving average price is $16.75 and its 200 day moving average price is $16.54. The company has a market capitalization of $214.92 million, a price-to-earnings ratio of 18.86 and a beta of 0.40.

SWK (NASDAQ:SWKH) last released its earnings results on Wednesday, March 19th. The company reported $0.54 earnings per share for the quarter, missing the consensus estimate of $0.94 by ($0.40). The company had revenue of $12.36 million during the quarter, compared to the consensus estimate of $9.70 million. SWK had a return on equity of 5.07% and a net margin of 26.51%.

SWK Company Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.